About
Technology
Issues
FAQ
Links
Official Page
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.